We are live on ! Find out more
CRMD icon

CorMedix
CRMD

101 hedge funds and large institutions have $71.4M invested in CorMedix in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

10% more funds holding

Funds holding: 92 → 101 (+9)

8% more capital invested

Capital invested by funds: $66.2M → $71.4M (+$5.21M)

2.01% more ownership

Funds ownership: 32.64% → 34.65% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

63% less call options, than puts

Call options by funds: $551K | Put options by funds: $1.51M

Holders
101
Holders Change
+9
Holders Change %
+9.78%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
17
Increased
37
Reduced
20
Closed
8
Calls
$551K
Puts
$1.51M
Net Calls
-$955K
Net Calls Change
+$292K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.27M
2
BlackRock
BlackRock
New York
+$1.2M
3
AFM
Anson Funds Management
Texas
+$685K
4
State Street
State Street
Massachusetts
+$661K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$601K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$1.55M
2
Citadel Advisors
Citadel Advisors
Florida
-$701K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$555K
4
Millennium Management
Millennium Management
New York
-$293K
5
OQS
Occudo Quantitative Strategies
Florida
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAN
76
Cetera Advisor Networks
California
$45.7K +$41.8K +12,152 New
Truist Financial
77
Truist Financial
North Carolina
$45.1K – – –
MML Investors Services
78
MML Investors Services
Massachusetts
$41K – – –
BCM
79
Bayesian Capital Management
New York
$39.6K +$36.2K +10,519 New
BC
80
Burney Company
Virginia
$37.6K – – –
PA
81
Pinnacle Associates
New York
$37.6K – – –
PWMAG
82
Pinnacle Wealth Management Advisory Group
New Jersey
$37.6K – – –
AF
83
Advisornet Financial
Minnesota
$36.5K – – –
California State Teachers Retirement System (CalSTRS)
84
California State Teachers Retirement System (CalSTRS)
California
$34K -$8.46K -2,458 -21%
Citigroup
85
Citigroup
New York
$29K +$26.5K +7,702 +33,487%
Legal & General Group
86
Legal & General Group
United Kingdom
$23.2K +$2.08K +606 +11%
AB
87
Amalgamated Bank
New York
$23K -$1.54K -448 -7%
AIP
88
Ameritas Investment Partners
Nebraska
$13.9K – – –
Fidelity Investments
89
Fidelity Investments
Massachusetts
$11.9K +$9.16K +2,663 +521%
Osaic Holdings
90
Osaic Holdings
Arizona
$10.2K -$3.23K -940 -26%
MLICM
91
Metropolitan Life Insurance Company (MetLife)
New York
$9.23K – – –
NRG
92
Nemes Rush Group
Michigan
$7.52K – – –
PAI
93
Pittenger & Anderson Inc
Nebraska
$2.29K – – –
NA
94
NewEdge Advisors
Louisiana
$1.88K +$1.72K +500 New
SWM
95
Spire Wealth Management
Virginia
$652 – – –
AF
96
Allworth Financial
California
$527 +$482 +140 New
NL
97
NVWM LLC
Pennsylvania
$470 -$344 -100 -44%
FFA
98
Farther Finance Advisors
California
$399 +$365 +106 New
Russell Investments Group
99
Russell Investments Group
United Kingdom
$308 -$151 -44 -35%
HI
100
Harbour Investments
Wisconsin
$188 – – –
1 2 3
4
5

CRMD Hedge Fund Activity: Q4 2023 in Review

101 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2023, worth a combined $71.4M — up 7.9% from $66.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CRMD positions and 8 closed out — a net gain of 9 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.27M. The largest seller was Marshall Wace, cutting an estimated $1.55M.

  • 101 institutional investors held CorMedix (CRMD) as of Q4 2023, up from 92 in Q3 2023.
  • Funds reported $71.4M of CorMedix stock for Q4 2023, up 7.9% quarter-over-quarter.
  • 17 funds opened new CorMedix positions in Q4 2023 and 8 closed out, a net change of +9 holders.
  • The largest CorMedix buyer in Q4 2023 was Morgan Stanley, an estimated $1.27M added.
  • The largest CorMedix seller in Q4 2023 was Marshall Wace, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2023.